Evaluation of nutritional status in patients undergoing hematopoietic SCT

被引:54
作者
Hadjibabaie, M. [2 ]
Iravani, M. [1 ]
Taghizadeh, M. [2 ]
Ataie-Jafari, A. [3 ]
Shamshiri, A. R. [1 ]
Mousavi, S. A. [1 ]
Alimoghaddam, K. [1 ]
Hosseini, S. [3 ]
Ghavamzadeh, A. [1 ]
机构
[1] Univ Tehran Med Sci, Hematol Oncol & SCT Res Ctr, Dept Hematol Oncol, Shariati Hosp, Tehran 14114, Iran
[2] Univ Tehran Med Sci, Fac Pharm, Dept Clin Pharm, Tehran 14114, Iran
[3] Univ Tehran Med Sci, Dept Nutr, Endocrinol & Metab Res Ctr, Tehran 14114, Iran
关键词
hematopoietic SCT; nutritional status; nutrition assessment; body mass index;
D O I
10.1038/bmt.2008.188
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The aims of this study were to establish the nutritional status of patients during hematopoietic SCT (HSCT) and to determine if body mass index (BMI) is a valid indicator of nutritional status in this population when compared with nitrogen balance (NB). In total, 50 patients were enrolled (mean age: 25.7 +/- 9.0 years). Patients (14%) were underweight (BMI < 18.5 kg/m(2)), 58% in a normal BMI (between 18.5 and 24.9 kg/m(2)) and 28% were overweight or obese (BMI >= 25 kg/m(2)). NB dropped after transplantation and increased from days + 5 to + 20 after transplantation (P = 0.006). There was a significant negative relationship between patients' BMI and time to engraftment (r = -0.45, P = 0.001). Engraftment of underweight patients was 3.0 days (P = 0.002) and 4.0 days (P < 0.001) later than in normal and overweight or obese patients, respectively. There was no significant correlation between NB before transplantation and time to engraftment (r = -0.22, P = 0.16). The results of this study demonstrate that patients undergoing HSCT may have suboptimal nutritional status and that pre-HSCT-BMI rather than NB may have a greater correlation in HSCT patients with the time of engraftment. Therefore, it may be useful to consider patient's BMI before transplantation for earlier engraftment time.
引用
收藏
页码:469 / 473
页数:5
相关论文
共 34 条
  • [1] AKER SN, 1983, NUTR SUPPORT SERV, V3, P22
  • [2] Reassessing the definition of myeloid engraftment after autotransplantation:: it is not necessary to see 0.5 X 109/l neutrophils on 3 consecutive days to define myeloid recovery
    Ali, MY
    Oyama, Y
    Monreal, J
    Winter, J
    Tallman, M
    Gordon, LI
    Williams, S
    Singhal, S
    Mehta, J
    [J]. BONE MARROW TRANSPLANTATION, 2002, 30 (11) : 749 - 752
  • [3] BROSS DS, 1984, BLOOD, V63, P1265
  • [4] CHENEY CL, 1987, CANCER, V59, P1515, DOI 10.1002/1097-0142(19870415)59:8<1515::AID-CNCR2820590821>3.0.CO
  • [5] 2-D
  • [6] COMPARISON OF METHODS OF ESTIMATING BODY-FAT IN NORMAL SUBJECTS AND CANCER-PATIENTS
    COHN, SH
    ELLIS, KJ
    VARTSKY, D
    SAWITSKY, A
    GARTENHAUS, W
    YASUMURA, S
    VASWANI, AN
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1981, 34 (12) : 2839 - 2847
  • [7] DONALDSON SS, 1979, CANCER, V43, P2036, DOI 10.1002/1097-0142(197905)43:5+<2036::AID-CNCR2820430712>3.0.CO
  • [8] 2-7
  • [9] GAUVREAUSTERN JM, 1989, J AM DIET ASSOC, V89, P367
  • [10] CLINICAL MANIFESTATIONS OF GRAFT VERSUS HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONORS
    GLUCKSBERG, H
    STORB, R
    FEFER, A
    BUCKNER, CD
    NEIMAN, PE
    CLIFT, RA
    LERNER, KG
    THOMAS, ED
    [J]. TRANSPLANTATION, 1974, 18 (04) : 295 - 304